Suppr超能文献

箭毒碱在大鼠肝脏溶酶体中的定位。体内溶酶体摄取、胆汁排泄及奎纳克林的置换作用

Localization of d-tubocurarine in rat liver lysosomes. Lysosomal uptake, biliary excretion and displacement by quinacrine in vivo.

作者信息

Weitering J G, Lammers W, Meijer D K, Mulder G J

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;299(3):277-81. doi: 10.1007/BF00500321.

Abstract

In the rat d-tubocurarine is taken up by the liver and excreted in bile. A fraction of the drug is taken up very rapidly by lysosomes. This lysosomal localization of the drug was demonstrated by purification of Triton WR 1339 loaded lysosomes ('tritosomes') on a sucrose density gradient by flotation; 3H-labeled d-tubocurarine was accumulated in the same fractions as acid phosphatase activity. Lysosome-bound d-tubocurarine is not available for biliary excretion and remains in the lysosomes even when the cytosolic concentration decreases to very low levels. The biliary excretion rate was linearly related to the amount of d-tubocurarine present in the cytosol. Lysosomal uptake of d-tubocurarine was decreased or prevented by the basic drug quinacrine in vivo. The lysosomal storage of d-tubocurarine is discussed in relation to its relevance for the clinical use of this and related drugs.

摘要

在大鼠体内,d-筒箭毒碱被肝脏摄取并经胆汁排泄。一部分药物被溶酶体迅速摄取。通过在蔗糖密度梯度上进行浮选纯化负载曲拉通WR 1339的溶酶体(“曲拉通体”),证实了药物在溶酶体中的定位;3H标记的d-筒箭毒碱与酸性磷酸酶活性积聚在相同的组分中。与溶酶体结合的d-筒箭毒碱无法用于胆汁排泄,即使胞质浓度降至极低水平,它仍留在溶酶体中。胆汁排泄率与胞质中d-筒箭毒碱的含量呈线性相关。在体内,碱性药物奎纳克林可降低或阻止d-筒箭毒碱被溶酶体摄取。结合其与该药物及相关药物临床应用的相关性,对d-筒箭毒碱在溶酶体中的储存进行了讨论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验